Ethics of AI in Healthcare: More Than Just Compliance

Updated on August 9, 2025

Artificial intelligence is no longer a future promise in healthcare; it’s already here, influencing how clinicians diagnose illness, how treatments are tailored, and how healthcare systems operate behind the scenes. From triaging patients in emergency rooms to predicting disease outbreaks, AI is rapidly embedding itself into the decision-making fabric of modern medicine. But as healthcare leaders integrate these tools into clinical practice, a crucial distinction often gets lost in the excitement over innovation: Just because AI complies with regulations doesn’t mean it’s ethically sound. 

Compliance with laws like HIPAA or oversight by agencies like the FDA provides an important baseline, ensuring data privacy, safety, and efficacy. But those regulations are not designed to answer deeper ethical questions — questions about fairness, accountability, and patient autonomy. What happens when an AI system is technically accurate but consistently underperforms for a particular demographic group? Or when a predictive model reinforces existing disparities in care? These are issues that lie beyond the reach of compliance and must be addressed through ethical scrutiny from the outset.  

Ethical AI in healthcare must be guided by long-standing principles of bioethics, adapted for a digital age. Beneficence, the commitment to act in the patient’s best interest, means AI should be used not merely to make healthcare more efficient, but to tangibly improve patient outcomes. Non-maleficence demands that AI tools undergo rigorous testing to minimize harm, including the often-overlooked harms that come from biased data or misleading outputs.  

Autonomy reminds us that patients have the right to make informed decisions about their care, which becomes more complex when that care is shaped by algorithms that patients (and sometimes clinicians) don’t fully understand. Justice, perhaps the most pressing concern in today’s health systems, demands equitable treatment across populations, particularly for communities historically marginalized in medicine. Finally, accountability ensures that when AI systems fail, because some inevitably will, there’s clarity about who is responsible and how the failure will be addressed.  

These ethical anchors are more than academic concepts. They directly influence how AI tools function in clinical practice. When implemented thoughtfully, AI can support a more proactive, individualized approach to medicine. But poorly governed AI risks depersonalizing care. Clinicians may rely too heavily on recommendations they don’t understand, patients may feel reduced to data points, and trust in the system can erode if outcomes feel inexplicable or unjust. This is especially true when AI systems rely on training data that fails to represent the full diversity of patient populations, leading to recommendations that are accurate in general but dangerously off-mark for individuals from underrepresented groups.  

One of the most challenging dynamics arises when AI-generated recommendations conflict with a clinician’s judgment or a patient’s wishes. These disagreements can be clinical, ethical, or both. Should an oncologist follow an algorithm’s suggestion for a treatment plan, even if it contradicts their own experience? What if a patient chooses to reject an AI-assisted diagnosis in favor of a second opinion or alternative care? Such moments are already unfolding in real clinical settings. 

The solution lies in building AI systems that offer more than just outputs. They must provide explainability: clear reasoning behind each recommendation, an assessment of confidence, and context that clinicians can interpret. This allows clinicians to remain the final decision-makers, using AI as a tool rather than a directive, and allows patients to remain actively engaged in their care.  

Explainability, however, raises its own tensions, especially when the most powerful AI models, such as deep learning algorithms, are also the most opaque. In some cases, not even the developers can fully explain how the AI arrives at a given conclusion. While such complexity might be tolerable in low-risk settings like administrative optimization, it’s untenable in high-stakes clinical decisions. In those contexts, transparency isn’t optional. Healthcare organizations must weigh the benefits of model accuracy against the cost of interpretability, and in many cases, choose to sacrifice a small degree of performance in favor of transparency and trust.  

Ethical design can’t be retrofitted once the AI is built. It has to start from the beginning. Developers must ensure that the data used to train AI systems is diverse and representative of the real-world populations the tools are meant to serve. Teams building these technologies should include not only engineers and data scientists, but also clinicians, ethicists, and patient advocates, who can flag potential blind spots early on. Documentation of model assumptions, limitations, and performance across subgroups should be standard practice. Ethical design also requires careful impact assessment: weighing who benefits, who might be harmed, and how potential harms can be mitigated before a single line of code affects a patient’s life.  

Once deployed, AI in healthcare must be monitored continuously. Models evolve over time as they are exposed to new data and environments, which means their performance — and their risks — can shift. Ethical oversight cannot be a one-time checkpoint. Instead, healthcare institutions should establish dedicated ethics review committees, composed of interdisciplinary stakeholders who can assess both new implementations and ongoing performance. These bodies must have the authority and independence to pause or revise deployments when issues arise and should be transparent in their evaluations to maintain public trust.  

At Brillio, we believe that AI should enhance the human dimensions of healthcare, not replace them. That vision is grounded in empathy, inclusivity, and humility as much as in technical expertise. Ethical AI is not a feature or a phase. It is a framework that should shape how we imagine, build, and deploy these technologies at every stage. It means designing systems that patients and providers can trust, preserve dignity and autonomy, and work equally well for everyone, not just the majority.   

The future of AI in healthcare holds immense promise. What it ultimately delivers will depend on how thoughtfully and ethically we choose to shape its role. 

Avantika Sharma
Avantika Sharma
Global Head of Healthcare at Brillio

Avantika Sharma is the Global Head of Healthcare at Brillio. A strategic senior executive with extensive experience in digital consulting, customer experience, and product strategy, she is passionate about addressing complex challenges in the healthcare sector through innovation. Committed to making quality care more accessible and affordable worldwide, she brings a forward-thinking approach to driving digital transformation in the industry. A strong advocate for Women in Tech, Avantika is dedicated to championing diversity and advancing women into leadership roles across both the technology and healthcare landscapes.